Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. mammowave

MammoWave

The first ultra-high sensitive breast imaging device based on non-ionizing safe microwave

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MammoWave project word cloud

Explore the words cloud of the MammoWave project. It provides you a very rough idea of what is the project "MammoWave" about.

limiting    healthcare    pregnancy    device    mammography    diagnosis    image    females    radiation    cup    marketing    hospitals    wave    plan    screening    age    complete    commercialization    scanner    transmit    prone    position    completely    additional    doctors    strategy    accurate    safe    negative    fast    establishing    signals    patient    ionizing    mammowave    first    tumor    unnecessary    electromagnetic    tissue    distress    performing    hospital    antennas    private    suspected    women    implies    directions    innovative    exposed    capture    patients    industrialization    battle    specificity    rate    breast    receive    regular    chain    outcome    cure    configured    harmful    positive    supply    elaboration    antenna    defer    trials    market    model    false    algorithm    measured    detection    consist    planning    paramount    receiving    techniques    reconstruction    departments    signal    huygens    imaging    cancer    business    azimuth    reflected    time    microwave    reduce    clinical    illness    incidence    clinics    moved    sound    hold    replying   

Project "MammoWave" data sheet

The following table provides information about the project.

Coordinator		 UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA 

Organization address
address: VIA SANTA MARIA DELLA SPINA 25
city: FRAZIONE RIVOTORTO
postcode: 6081
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.ubt-tech.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA IT (FRAZIONE RIVOTORTO) coordinator 50˙000.00

Map

 Project objective

Breast cancer is the most common cancer in females. Regular screening is of paramount important for early diagnosis to reduce the incidence and increase the outcome of a cure. Current techniques based on ionizing radiation cannot be used in many cases. MammoWave is a mammography device based on safe microwave that enable a fast and accurate breast imaging allowing for an early detection of breast cancer, based on simple technology and low cost. MammoWave can be used any time, at any age and in any condition (pregnancy, specific illness etc.) for all patients since it does not use ionizing radiation. Defer to traditional mammography only cases positive for a first screening MammoWave, limiting the use of harmful radiation. The breast scanner consist of a cup that hold the breast of the patient in a prone position and of two antennas, one to transmit the microwave signal and one to receive. The breast is exposed to completely safe wave field. Both antennas are configured to be moved around the azimuth, to capture reflected electromagnetic field in all directions and measured by the receiving antenna. MammoWave is based on an innovative image reconstruction algorithm that processes the microwave signals according to the Huygens' principle: the result is able to identify the presence of any suspected tumor in the breast tissue. MammoWave addresses the market of hospitals, clinics and private doctors replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive and false-negative results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAMMOWAVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAMMOWAVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

HYBCOPTER (2016)

Hybrid multi copter with 6 times more flight time.

Read More